Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Childhood is a time filled with wondrous changes, as brain plasticity permits experiences to shape the immature brain to meet the demands of the environment. Change occurs at various levels—from neuroanatomy, including within a given region and its connectivity to other regions, to the function of neurotransmitter systems and their reactivity to pharmacological agents in the short‐ and long‐term. The nature and degree to which drug exposure influences the final adult topography is influenced greatly by the maturational phase of these critical factors. Moreover, evidence is slowly emerging that suggests that the long‐term effects of drug exposure are delayed and expressed once the vulnerable system reaches maturation (i.e., typically during adulthood). This phenomenon is known as neuronal imprinting and occurs when the effects of drug exposure outlast the drug itself. Thus, understanding the persistent effects critically depends on the window of observation. Embracing this concept should influence how we conduct preclinical assessments of developmental drug exposure, and ultimately how we conduct clinical assessments of drug efficacy, effectiveness, and safety for the treatment of childhood psychiatric disorders. In this article, we present a model to provide a heuristic framework for making predictions about imprinted effects of childhood drug exposure. We then review epidemiological data on attention deficit hyperactivity disorder (ADHD) and childhood depression, prescription practices, and what is known regarding the long‐term consequences of drug exposure in these populations. We conclude with a discussion of the current status of preclinical studies on juvenile stimulant exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
The adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Synaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645 · cited 4×
“For example, monoamine systems in the mammalian species exuberantly overproduce then reduce synapses and receptors in humans (Huttenlocher, 1979; Giedd et al., 1999a,b; Thompson et al., 2000; Sowell et al., 2001), primates (Lidow et al., 1991), and rats (Andersen et al., 1997a,b; Andersen et al.,…”
BackgroundInfluentialCastellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Trajectories of brain development: point of vulnerability or window of opportunity?
Andersen, S. L. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00005-8 · Cited by 1,503 · cited 9×
“As such, clinical researchers have begun to question the impact of these agents on the developing brain (Vitiello, 1998; Andersen, 2003).”
BackgroundInfluentialSelf-citationMood disorders in children and adolescents: an epidemiologic perspective
Kessler, R. C., Avenevoli, S., & Ries Merikangas, K. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01129-5 · Cited by 1,181
Major depressive disorder in older adolescents
Lewinsohn, P. M., Rohde, P., & Seeley, J. R. (1998) · Clinical Psychology Review · doi:10.1016/s0272-7358(98)00010-5 · Cited by 1,078
THE BEHAVIOR OF CHILDREN RECEIVING BENZEDRINE
Bradley, C. (1937) · American Journal of Psychiatry · doi:10.1176/ajp.94.3.577 · Cited by 1,035
Sowell, E. R., Thompson, P. M., Tessner, K. D., & Toga, A. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08819.2001 · Cited by 983
Hyperactive Boys Almost Grown Up: I. Psychiatric Status
Gittelman, R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330017002 · Cited by 977
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863 · cited 7×
“Prescription rates for fluoxetine rose 1.8-fold between 1991 and 1995 in elementary and preschool children in the United States (Zito et al., 2000), whereas a 10-fold increase in the use of selective serotonin reuptake inhibitors (SSRI’s) in children 5 years of age and younger was observed between…”
BackgroundInfluentialGrowth patterns in the developing brain detected by using continuum mechanical tensor maps
Thompson, P. M., Giedd, J. N., Woods, R. P., MacDonald, D., Evans, A. C., & Toga, A. W. (2000) · Nature · doi:10.1038/35004593 · Cited by 850
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845
Neurobiology of attention-deficit hyperactivity disorder
Faraone, S. V., & Biederman, J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00240-6 · Cited by 811
CASEY, B. J., CASTELLANOS, F. X., GIEDD, J. N., MARSH, W. L., HAMBURGER, S. D., SCHUBERT, A. B., VAUSS, Y. C., VAITUZIS, A. C., DICKSTEIN, D. P., SARFATTI, S. E., et al. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199703000-00016 · Cited by 800 · cited 2×
“Morphometric MRI studies report reductions in the corpus callosum, prefrontal cortex, caudate nucleus, and the globus pallidus in some (Castellanos et al., 1994; Casey et al., 1997; Faraone and Biederman, 1998; Lou et al., 1998), but not all studies (Rubia et al.”
BackgroundSolanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677 · cited 1×
“Hypofunctioning of the cortex has been proposed to explain reduced attention and impulsiveness (Dinn et al., 2001), and is improved by stimulant pharmacotherapy (Solanto, 1998).”
BackgroundReward deficiency syndrome: genetic aspects of behavioral disorders
Comings, D. E., & Blum, K. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26022-6 · Cited by 621
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Vaswani, M., Linda, F. K., & Ramesh, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00338-x · Cited by 612
Psychiatric Diagnoses of Treatment-Seeking Cocaine Abusers
Rounsaville, B. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250045005 · Cited by 605
Amygdala Response to Fearful Faces in Anxious and Depressed Children
Thomas, K. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.1057 · Cited by 582 · cited 1×
“, 2001); and blunted amygdalar response to fearful faces (Thomas et al., 2001).”
BackgroundCerebellum in attention-deficit hyperactivity disorder: A morphometric MRI study
Berquin, P. C., Giedd, J. N., Jacobsen, L. K., Hamburger, S. D., Krain, A. L., Rapoport, J. L., & Castellanos, F. X. (1998) · Neurology · doi:10.1212/wnl.50.4.1087 · Cited by 564 · cited 1×
“The cerebellar vermis also plays a role in the pathophysiology of ADHD (Houk and Wise, 1995; Berquin et al., 1998; Anderson et al., 2002a,b; Castellanos et al., 2002).”
BackgroundDevelopment of the dopaminergic innervation in the prefrontal cortex of the rat
Kalsbeek, A., Voorn, P., Buijs, R. M., Pool, C. W., & Uylings, H. B. M. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902690105 · Cited by 545
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1652 · Cited by 528
Krause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521 · cited 1×
“First, Krause et al. (2000) showed a reduction in dopamine transporter (DAT) after four weeks of MPH treatment in a previously unmedicated ADHD adult population.”
BackgroundPharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493
BIEDERMAN, J., WILENS, T., MICK, E., FARAONE, S. V., WEBER, W., CURTIS, S., THORNELL, A., PFISTER, K., JETTON, J. G., & SORIANO, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199701000-00013 · Cited by 476
KOVACS, M. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199606000-00010 · Cited by 441
Rapoport, J. L. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780210091010 · Cited by 434 · cited 1×
“, 1999a,b); however, stimulant use produces dysphoria in children, precluding its abuse liability (Rapoport et al., 1980).”
BackgroundDevelopment and natural history of mood disorders
Costello, E. J., Pine, D. S., Hammen, C., March, J. S., Plotsky, P. M., Weissman, M. M., Biederman, J., Goldsmith, H. H., Kaufman, J., Lewinsohn, P. M., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01372-0 · Cited by 430
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Gifford, A., Hitzemann, R., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1440 · Cited by 406
Volkow, N. D., Wang, G.-J., Fowler, J. S., Hitzemann, R., Angrist, B., Gatley, S. J., Logan, J., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.19 · Cited by 405
Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys
Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978) · Science · doi:10.1126/science.341313 · Cited by 373 · cited 3×
“Upon closer examination, Rapoport and colleagues (Rapoport et al., 1978) found that acute stimulant administration improves performance in typical children as well, suggesting that the effects of MPH are not paradoxical, but rather exert rate-dependent effects on motor and cognitive activity (Rapoport et al.”
BackgroundNew evidence for neurotransmitter influences on brain development
Levitt, P., Harvey, J. A., Friedman, E., Simansky, K., & Murphy, E. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01028-4 · Cited by 362 · cited 1×
“Change occurs at various levels—from neuroanatomy, including within a given region and its connectivity to other regions, to the function of neurotransmitter systems and their reactivity to pharmacological agents in the short- and long-term.”
BackgroundKuczenski, R., & Segal, D. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07264.2002 · Cited by 316 · cited 4×
“Lately, efforts to more appropriately model childhood stimulant exposure are underway (Andersen et al., 2002b; Kuczenski and Segal, 2002) and are focused on much lower doses (2 mg/kg or lower) and route of administration (Kuczenski and Segal, 2002).”
BackgroundInfluentialEtiology of early age onset substance use disorder: A maturational perspective
TARTER, R., VANYUKOV, M., GIANCOLA, P., DAWES, M., BLACKSON, T., MEZZICH, A., & CLARK, D. B. (1999) · Development and Psychopathology · doi:10.1017/s0954579499002266 · Cited by 272
Altered responsiveness to cocaine in rats exposed to methylphenidate during development
Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C., & Carlezon, W. A. (2002) · Nature Neuroscience · doi:10.1038/nn777 · Cited by 259
Self-citationBrandon, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00281-0 · Cited by 259
High Midbrain [ 18 F]DOPA Accumulation in Children With Attention Deficit Hyperactivity Disorder
Ernst, M., Zametkin, A. J., Matochik, J. A., Pascualvaca, D., Jons, P. H., & Cohen, R. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1209 · Cited by 256
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248 · cited 1×
“…these circumstances, exposure to low doses of the stimulant produces a long-lasting aversion to a moderate dose of cocaine (Andersen et al., 2002a) and other natural substances (Bolanos et al., 2003) and increases depressive-like symptoms (Carlezon et al., 2003) and anxiety (Bolanos et al., 2003).”
BackgroundSelf-citationLidow, M. S., Goldman-Rakic, P. S., & Rakic, P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10218 · Cited by 232
Whitaker-Azmitia, P. M. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06668-2 · Cited by 226 · cited 2×
“In cell culture, elevated levels of serotonin decrease neuronal branching (Whitaker-Azmitia and Azmitia, 1986; Whitaker-Azmitia, 1991), which contrasts findings obtained from adult exposure studies showing antidepressantenhanced neurogenesis (Gould, 1999; Malberg et al.”
BackgroundMoll, G. H., Mehnert, C., Wicker, M., Bock, N., Rothenberger, A., Rüther, E., & Huether, G. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00182-0 · Cited by 204
Luby, J. L., Heffelfinger, A., Mrakotsky, C., Brown, K., Hessler, M., & Spitznagel, E. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1248 · Cited by 184
Hechtman, L., & Weiss, G. (1986) · The Canadian Journal of Psychiatry · doi:10.1177/070674378603100614 · Cited by 156
Abnormal T2 relaxation time in the cerebellar vermis of adults sexually abused in childhood:
Anderson, C. M., Teicher, M. H., Polcari, A., & Renshaw, P. F. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00047-6 · Cited by 139 · cited 2×
“The cerebellar vermis also plays a role in the pathophysiology of ADHD (Houk and Wise, 1995; Berquin et al., 1998; Anderson et al., 2002a,b; Castellanos et al., 2002).”
BackgroundEl Mansari, M. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00045-f · Cited by 128 · cited 1×
“…in the terminal fields (Malagie et al., 2001; Malagie et al., 2002), including the frontal cortex (Blier et al., 1984; O’Connor and Kruk, 1994; el Mansari et al., 1995; Moret and Briley, 2000; Newman et al., 2000), desensitize, which is believed to underlie the proposed therapeutic action of…”
BackgroundKim, B. N., Lee, J. S., Cho, S. C., & Lee, D. S. (2001) · Yonsei Medical Journal · doi:10.3349/ymj.2001.42.1.19 · Cited by 88
Pine, D. S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386888 · Cited by 73
Degree of neuronal activation following FG-7142 changes across regions during development
Lyss, P. J., Andersen, S. L., LeBlanc, C. J., & Teicher, M. H. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00069-3 · Cited by 37
Self-citation
Cited by
Cadmium Exposure and Neurodevelopmental Outcomes in U.S. Children
Ciesielski, T., Weuve, J., Bellinger, D. C., Schwartz, J., Lanphear, B., & Wright, R. O. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104152 · Cited by 255
Stimulants and the developing brain
Andersen, S. L. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.009 · Cited by 168
Self-citationNicotine exposure during adolescence induces a depression-like state in adulthood
Iñiguez, S. D., Warren, B. L., Parise, E. M., Alcantara, L. F., Schuh, B., Maffeo, M. L., Manojlovic, Z., & Bolaños-Guzmán, C. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.220 · Cited by 157
“Nevertheless, our findings are in agreement with the notion that the full spectrum of effects after drug exposure during development may not appear until later in life (ie ‘drug effects incubate’; Andersen and Navalta, 2004), and with recent epidemiological findings indicating that novice adolescent smokers show signi…”
Brain Neuroplasticity in Healthy, Hyperactive and Psychotic Children: Insights from Neuroimaging
Rapoport, J. L., & Gogtay, N. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301553 · Cited by 132
Leussis, M. P., Lawson, K., Stone, K., & Andersen, S. L. (2008) · Synapse · doi:10.1002/syn.20483 · Cited by 95
“The lack of an effect of tianeptine may be related to the potentially adverse effects of elevated serotonin levels during development (Ansorge et al., 2004), although it is likely that the sensitive period for this effect is over before weaning [reviewed in (Andersen and Navalta, 2004)].”
Self-citation
Metadata
- Authors
- Andersen, S. L., & Navalta, C. P.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2004-08
- Volume
- 22
- Issue
- 5-6
- Pages
- 423-440
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W2068676696
- Cited by
- 142
- References
- 53
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.